Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The European Reference Laboratory for Glycohemoglobin (ERL) is a specialized diagnostic and standardization facility focused on the measurement of glycated hemoglobin (HbA1c). Based in Zwolle, Netherlands, the ERL serves as a central reference point for the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the National Glycohemoglobin Standardization Program (NGSP). The laboratory provides calibration services, proficiency testing, and quality control materials to ensure global consistency in diabetes monitoring. It plays a critical role in maintaining the traceability of HbA1c results to international reference standards. The organization works closely with diagnostic manufacturers to certify their methods against established reference systems, supporting the clinical management of patients with diabetes mellitus on a global scale.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on European Reference Laboratory for Glycohemoglobin.